G9147 Outpatient IV Insulin | HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS G9147: Outpatient Intravenous Insulin Treatment (OIVIT)

HCPCS Level II code G9147 designates outpatient intravenous insulin treatment (OIVIT), administered pulsatilely or continuously and guided by metabolic measurements such as respiratory quotient, urine urea nitrogen, glucose, and potassium. This code captures a specialized outpatient infusion service focused on precise metabolic control rather than routine glucose management. Nationally, its use reflects care pathways for complex metabolic or nutritional scenarios where IV insulin titration is driven by laboratory or physiologic monitoring.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage considerations and where the code fits clinically, plus benchmarks and policy context relevant to outpatient infusion services. The publication outlines expected service settings, common documentation elements implied by the code description, and implications for billing workflows.

The content provides actionable clarity on the clinical intent of G9147, typical sites of service, and what analysts and billing teams should expect when encountering claims with this code. Data not available in the input are noted where applicable; the focus remains on national applicability and payer scope rather than state-specific rules.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9147HCPCS Level IIoutpatient infusionintravenous insulinmetabolic monitoringOIVIThospital outpatientinfusion centerbilling guidance

Billing Code Overview

HCPCS Level II code G9147 describes outpatient intravenous insulin treatment (OIVIT), delivered either pulsatile or continuous, guided by measurements of one or more metabolic parameters such as respiratory quotient, urine urea nitrogen (UUN), arterial, venous or capillary glucose, and/or potassium concentration. The service represents a targeted metabolic management therapy using IV insulin with biochemical monitoring to guide dosing and duration.

Service type: Outpatient infusion/metabolic therapy

Typical site of service: Outpatient infusion center or hospital outpatient department

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult hospitalized for severe metabolic derangement such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), or a critically ill surgical or medical patient with significant hyperglycemia requiring tightly titrated intravenous insulin therapy. The patient is managed in an inpatient step-down unit, intensive care unit, or an outpatient infusion center with continuous nursing and laboratory monitoring. The clinical workflow begins with physician assessment and order for G9147 outpatient intravenous insulin treatment (pulsatile or continuous). Baseline labs are drawn including point-of-care glucose, serum potassium, and basic metabolic panel; urine urea nitrogen (UUN) and respiratory quotient measurements are obtained when metabolic substrate monitoring is required. An infusion pump is programmed for continuous or pulsatile insulin delivery; glucose and potassium are measured frequently (capillary, venous, or arterial as indicated) and insulin rate adjusted per protocol guided by these measurements. Nursing documents infusion rates, measurement results, and any rate adjustments. Electrolytes, especially potassium, are replaced proactively. The service concludes when the patient is clinically stable, transitioned to subcutaneous insulin, or transferred to a higher or lower level of care. Typical sites of service include hospital outpatient infusion centers, emergency departments that observe patients, hospital observation units, and specialized outpatient metabolic clinics. Common clinical indications include acute severe hyperglycemia, DKA/HHS stabilization, perioperative glycemic management for insulin-dependent patients, and metabolic monitoring-directed insulin therapy in complex nutrition or catabolic states.

Coding Specifications

Modifier	Description	When to Use

HCPCS G0156: Home Health/Hospice Aide Services, 15-Minute Units

HCPCS-G9219-PCP-PROPHYLAXIS-NOT-PRESCRIBED-MEDICAL-REASON

HCPCS G9219: PCP Prophylaxis Not Prescribed for Medical Reason

HCPCS-G9530-HEAD-CT-ORDER-FOR-MINOR-BLUNT-HEAD-TRAUMA

HCPCS G9530: Head CT Order for Minor Blunt Head Trauma

HCPCS-G9247-HIV-CARE-ENGAGEMENT-90-DAY-INTERVAL

HCPCS G9247: HIV Care Engagement Over 90-Day Interval

HCPCS-G0051-HOSPICE-PATIENT-REPORTING-CURRENT-MONTH

HCPCS G0051: Patients Under Hospice Care in Reporting Month

HCPCS-G9984-REMOTE-IN-HOME-EVALUATION-MANAGEMENT-ESTABLISHED-PATIENT

HCPCS G9984: Remote In-Home Evaluation and Management Visit

HCPCS-G8961-CARDIAC-STRESS-IMAGING-PREOPERATIVE-LOW-RISK

HCPCS G8961: Cardiac Stress Imaging for Preoperative Evaluation

HCPCS-G9902-TOBACCO-USE-SCREENING-IDENTIFIED-USER

HCPCS G9902: Patient Screened for Tobacco Use, Identified as User

HCPCS-G0918-CATARACT-SATISFACTION-NOT-ACHIEVED-90-DAYS

HCPCS G0918: Satisfaction with Care Not Achieved Within 90 Days Following Cataract Surgery

HCPCS-G9767-EVALUATION-ENDOVASCULAR-STROKE-TREATMENT-INPATIENT

HCPCS G9767: Evaluation for Endovascular Stroke Treatment in Hospitalized Patients

Showing 1–10 of 1996

`22`	Increased procedural services	Use when the IV insulin therapy required substantially greater resources or complexity than typical, documented and justified.
`23`	Unusual anesthesia	Use if unusual anesthesia was provided in conjunction with the procedure (rare for this outpatient IV insulin service).
`52`	Reduced services	Use if the insulin infusion was started but significantly reduced or abbreviated compared with the full service.
`53`	Discontinued procedure	Use if the insulin infusion was initiated but discontinued due to patient instability or other documented reason prior to completion.
`54`	Surgical care only	Not typically applicable; use if another provider billed pre/post care separately and this provider billed only intra-procedural management.
`55`	Postoperative management only	Use only if provider billed only for post-procedure management separate from initial therapy.
`56`	Preoperative management only	Use if the claim is for pre-infusion preparation services only.
`62`	Two surgeons	Rarely applicable; use if two qualified clinicians simultaneously managed the infusion and both meet billing criteria.
`80`	Assistant surgeon	Use when an assistant surgeon participated and billing requires this modifier (uncommon for IV insulin).
`82`	Assistant surgeon (when qualified resident not available)	Use if an assistant performed duties in absence of a qualified resident.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for certain payors	Use when an advanced practice clinician furnished part or all of the service per payer rules.
`QK`	Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals	Use only if anesthesia medical direction meets criteria; rarely used for this service.
`QX`	CRNA service with medical direction by a physician	Use only if a certified registered nurse anesthetist provided anesthesia-related services linked to this procedure.
`QY`	Medical direction of one CRNA by an anesthesiologist	Use if applicable under payer rules when anesthesia was directed.

Taxonomy Code	Specialty	Notes
`207RC0000X`	Internal Medicine	Hospitalists or internists commonly direct IV insulin therapy and metabolic monitoring.
`208000000X`	Emergency Medicine	Emergency physicians initiate and manage IV insulin infusions in the ED or observation units.
`2086S0200X`	Critical Care Medicine	Intensivists manage continuous insulin infusions in ICU settings with complex monitoring.
`207L00000X`	Endocrinology	Endocrinologists provide protocol development and oversight for complex metabolic insulin regimens.
`363L00000X`	Nurse Practitioner	Advanced practice clinicians often provide direct infusion management under scope of practice.

ICD-10 Code	Description	Clinical Relevance
Data not available in the input.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96360`	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	May be billed for initial IV infusion management time when hydration is separately provided with insulin therapy in an outpatient infusion setting.
`96361`	Intravenous infusion, hydration; each additional hour	Use for additional hourly infusion time when prolonged IV fluid/infusion management accompanies insulin infusion.
`36415`	Collection of venous blood by venipuncture	Billed for routine venous blood draws used to measure glucose, electrolytes, and UUN guiding the insulin infusion.
`82947`	Glucose; quantitative, blood (except reagent strip)	Laboratory assay commonly performed repeatedly to guide insulin titration.
`83735`	Potassium; ion-selective electrode (ISE) method	Laboratory test used frequently to monitor and guide potassium replacement during insulin therapy.
`87086`	Urinalysis, by dipstick or tablet reagent; non-automated, with microscopy	May be used adjunctively; note that specific UUN measurement often requires quantitative urine chemistry billing tied to lab codes.

OpenPayer